Adherence Ensuring Better Patient Outcomes Lecture # 2 Ghadah Asaad Assiri,MSc May 2014.

Slides:



Advertisements
Similar presentations
Building an Integrated System for Personalizing Care Tim Johnson, MD Spring, 2014.
Advertisements

Clinical Trial Results. org Valvular Heart Disease and the Use of Dopamine Agonists for Parkinson’s Disease Renzo Zanettini, M.D.; Angelo Antonini, M.D.;
Improving Diabetes Outcomes by an Innovative Group Visit Model.
PHARMACIST-MANAGED DIABETES SERVICE IN A RURAL FREE CLINIC Katherine R. Gerrald, PharmD 1,2,3 ; Julie M. Sease, PharmD 1,2 ; Meg Franklin, PharmD, PhD.
Reductions in Regimen Distress Are Associated With Improved Management and Glycemic Control Over Time Featured Article: Danielle Hessler, Lawrence Fisher,
Multifaceted Intervention to Improve Medication Adherence and Secondary Prevention Measures (Medication Study) After Acute Coronary Syndrome Hospital Discharge.
Clare A Mackie Centre for Partnerships in Medicines for Health Economic Evaluation of a RCT of a ‘Medication Review Clinic’ in Patients Receiving Repeat.
Support and Assessment for Fall Emergencies (SAFE) Trial An evaluation of the costs and benefits of computerised on-scene decision support for emergency.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence January–February 2011.
Ambulatory care Prepared by: Nehad Ahmed. Ambulatory care is Primary care-based services and services provided from office-based specialists and hospital.
Jan D. Hirsch, BS Pharm, PhD Research Interests Pharmacoeconomics & Outcomes Research “Value” of Pharmacist Services & Pharmaceuticals - Economic, clinical.
An Automated Internet Behavioral Weight-Loss Program by Physician Referral: A Randomized Controlled Trial Featured Article: J. Graham Thomas, Tricia M.
SYNOPSIS OF THE PROTOCOL Title: Pregnancy Associated Breast Cancer (PABC); Prospective Data Registry in Saudi Arabia Sponsor: Oncology Department, King.
Shared Medical Visits Jauch Symposium – May 17, 2014.
Rapid Rise in Hypertension and Nephropathy in Youth With Type 2 Diabetes The TODAY clinical trial Featured Article: TODAY Study Group* Diabetes Care Volume.
Basma Y. Kentab MSc.. 1. Define ambulatory care 2. Describe the value of ambulatory care practices 3. Explore pharmacy services in some ambulatory care.
1 NHLBI/NEI National Institutes of Health NHLBI/NEI National Institutes of Health.
Evidence-Based Journal Article Presentation [Insert your name here] [Insert your designation here] [Insert your institutional affiliation here] Department.
Can pharmacists improve outcomes in hypertensive patients? Sookaneknun P (1), Richards RME (2), Sanguansermsri J(1), Teerasut C (3) : (1)Faculty of Pharmacy,
Evaluating clinical pharmacist impact on diabetes control: outcomes on hemoglobin A1c Mark Amoo PharmD Candidate, Dalton Walsh PharmD Candidate, Kalyani.
Figure. S1 Week Percent of VO 2peak Repeat CPET.
Experimental studies Jean-François Boivin 25 October 2010.
Lung-2015 Baltimore, USA July , 2015 Suhaj A.
Evidence-Based Medicine Presentation [Insert your name here] [Insert your designation here] [Insert your institutional affiliation here] Department of.
* Indicates p < 0.05 indicates p < 0.05 Evaluating Clinical Pharmacist Impact on Diabetes Control* Mary Ella Hill, Pharm. D. Candidate; Orijane Dalton,
Training Primary Care Pharmacists Paula Wilkinson Chief Pharmacist Mid-Essex CCG.
Federal Study of Adherence to Medications (FAME) Trial Presented at The American Heart Association Annual Scientific Session 2006 Presented by Dr. Allen.
Lecture 9: Analysis of intervention studies Randomized trial - categorical outcome Measures of risk: –incidence rate of an adverse event (death, etc) It.
The Diabetic Retinopathy Clinical Research Network Effect of Diabetes Education During Retinal Ophthalmology Visits on Diabetes Control (Protocol M) 11.
Critical Appraisal (CA) I Prepared by Dr. Hoda Abd El Azim.
Optimization of psychotropic drug prescription in nursing home patients with dementia: the PROPER study (PRescription Optimization of Psychotropic drugs.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence November-December 2012.
1 Improving Care for the Uninsured by Providing Links to Primary Care Susan H. Busch, Ph.D. 1 Sarah McCue Horwitz, Ph.D. 2 Kathleen M. B. Balestracci,
San Diego RCI Community Pharmacists on Care Team Pilot Annual Right Care Summit October 1, 2012 Berkeley, CA San Diego RCI.
Ross T. Tsuyuki, BSc(Pharm), PharmD, MSc, FCSHP, FACC Yazid NJ Al Hamarneh, BPharm, PhD Charlotte Jones, MD, PhD, FRCP(C) Brenda Hemmelgarn, MD, PhD, FRCP(C)
Presentation Developed for the Academy of Managed Care Pharmacy
LifeCIT Development and pilot evaluation of a web-supported programme of Constraint Induced Therapy following stroke (LifeCIT) Meagher C 1, Conlon A 2,
Date of download: 6/21/2016 From: Pharmacist-led Chronic Disease Management: A Systematic Review of Effectiveness and Harms Compared With Usual Care Ann.
Date of download: 6/21/2016 Copyright © The American College of Cardiology. All rights reserved. From: The Effectiveness of Pharmacist Interventions on.
Date of download: 6/24/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Use of a Blood Glucose Monitoring Manual to Enhance.
Effect of a Community-Based Self-help Management Program for Patients with Diabetes Mellitus Effect of a Community-Based Self-help Management Program for.
Angela Aziz Donnelly April 5, 2016
Tracy Ellis Programme Delivery Lead
Clinical Pharmacists' Recommendations in Critical Care Areas of an Egyptian Tertiary Care Hospital: Interventions Analysis and Effect on Direct Drug Cost.
An Automated, Pharmacist-Driven Initiative Improves Quality of Care for Staphylococcus aureus Bacteremia Eric Wenzler1, Fei Wang2, Debra Goff2, Beth Prier2,
Research Questions Does integration of behavioral health and primary care services, compared to simple co-location, improve patient-centered outcomes in.
“MOVEdiabetes” 12 months intervention
Can Primary Care Physicians Learn and Adopt Brief Motivational Interviewing Techniques in their Practice? Alan Adelman, MD, MS David Richard, MD Robert.
Assign membership into BFO/OBI branches
Canagliflozin: Real World Experience
ASPIRE Workshop 5: Application of Biostatistics
ASPIRE Workshop 5: Application of Biostatistics
Alcohol, Other Drugs, and Health: Current Evidence May-June, 2018
SAVE Trial design: Patients with moderate to severe obstructive sleep apnea (OSA) and known CV disease were randomized in a 1:1 fashion to either CPAP.
Medication Nonadherence in Gout
Rhematoid Rthritis Respiratory disorders
Panelists. One Size May Not Fit All: A New Aspirin Option for the High-Risk Patient.
Observational Studies vs. Randomized Controlled Trials (RCT)
Community Pharmacists Monitoring of Pulmonary Tuberculosis Outpatients (Preliminary Study)
Statins, Obesity, and Hyperlipidemia
Pharmacy practice and the healthcare system Ola Ali Nassr
Pharmaceutical care planning 2 Ola Ali Nassr
IMPACT OF PHARMACIST DELIVERED CARE IN THE COMMUNITY PHARMACY SETTING
ASPIRE Workshop 5: Application of Biostatistics
SYNOPSIS OF THE PROTOCOL
Patient education with or without manual therapy compared to a control group in patients with osteoarthritis of the hip. A proof-of-principle three-arm.
Community Pharmacists Monitoring of Pulmonary Tuberculosis Outpatients (Preliminary Study)
My PAH Patient.
Case-finding for depression in primary care: a randomized trial∗ ∗
Mean BP by visit - all patients
Presentation transcript:

Adherence Ensuring Better Patient Outcomes Lecture # 2 Ghadah Asaad Assiri,MSc May 2014

Example: RCT  Randomized controlled trial of clinical pharmacy management of patients with type 2 diabetes in an outpatient diabetes clinic in Jordan* *Jarab AS, Alqudah SG, Mukattash TL, Shattat G, Al-Qirim T: Randomized controlled trial of clinical pharmacy management of patients with type 2 diabetes in an outpatient diabetes clinic in Jordan. J Manag Care Pharm 2012; 18: 516–26.

Example.. Cont. Study design : randomized controlled trial Randomization :Patients with type 2 DM attending an outpatient diabetes clinic of a large teaching hospital were recruited,randomly assigned to either usual care or a pharmacist-led pharmaceutical care intervention program, using Minim software technique. Setting : outpatient diabetes clinic clinic at the Royal Medical Services (RMS) Hospital in Jordan. Duration of the study :over a 4-month period from January through April 2011 then 6 month assessment (until October 2011 ) Sample size: A total of 77 of 85 patients (90.6%) randomly assigned to the intervention group and 79 of 86 patients (91.9%) assigned to usual care had baseline and 6-month follow-up values.

Example.. Cont. OBJECTIVE: T o evaluate the impact of clinical pharmacist- led pharmaceutical care program on : 1- Primary clinical outcome of glycemic control (A1c) 2- Secondary outcomes, including BP, lipid values, self- reported medication adherence, and self-care activities for patients with type 2 diabetes

Example.. Cont

Example.. Cont.  Statistical test : SPSS software for statistical analysis P value of <0.05 was considered statistically significant  Follow up & monitoring : 6 months after the initial visit for each patient (e.g., a patient recruited in April 2011 was followed up in October 2011)

Example…Cont. Usual care Vs pharm-led pharmaceutical care intervention program Type of intervention : If required, initial adjustment of diabetes medication & antihypertensive medication as suggested by pharmacist. Structured diabetes education, including the importance of adherence and lifestyle that negatively affect blood pressure; providing patient with information leaflets. 20 minutes telephone consultation wit pharmacist every 8 weeks ( topics: currant medications, importance of adherence & treatment plan, possible concerns on the part of the patient ) Matthes J, Albus C.Improving adherance with medication- a selective letreture review based on the example of hypertention treatment. Medicine, Dtsch Arztebl Int 2014; 111(4): 41-7

Example…Cont. Adherence tool : Self-Reported Medication Adherence (Morisky Scale) Simple, validated 4-question survey assessed the likelihood that patients take their medications as prescribed Jarab AS, Alqudah SG, Mukattash TL, Shattat G, Al-Qirim T: Randomized controlled trial of clinical pharmacy management of patients with type 2 diabetes in an outpatient diabetes clinic in Jordan. J Manag Care Pharm 2012; 18: 516–26.

Example…Cont. QuestionsScore Do you forget to take your medications?To score the questionnaire, each “yes” response is given a score of 1, each “no” response is given a score of 0 (range 0 to 4) According to the Morisky classification, adherence is divided into 3 groups: high for those scoring 0, medium for those scoring (1 -2), low for those scoring (3-4) For the purpose of the present analysis, the patients were divided into 2 groups: those scoring 0 were considered adherent, and those scoring 1-4 were nonadherent. Are you careless about time of taking your medications? Do you stop taking your medications when you feel better? Do you stop taking your medications when you feel worse?

Example…Cont. Result : 1- Effect on clinical end point :Reduction in A1c. patients in the intervention group had a mean reduction of 0.8% in A1c Vs a mean increase of 0.1% from baseline in the usual care group (P = 0.019). 2- Effect on adherence :  significantly lower proportion of non adherent patients in the intervention group (28.6%) compared with the usual care group (64.6%) at the 6-month assessment

Example…Cont.  Compared with the usual care group, intervention patients who received the clinical pharmacy service showed significant improvement in self-reported medication adherence and lifestyle changes that represent the cornerstone in the management of type 2 diabetes.

Special population  For pediatric patients  give rewards and ensure medications are palatable5  For psychiatric patients  provide frequent follow-up. Choose well-tolerated medications. Provide positive reinforcement  For asymptomatic conditions such as Hypertension  Choose well-tolerated medications,  Consider cultural or language barriers that may affect adherence

Conclusion  Best possible decision about therapy should be reached according to clinical demand and patient preference  The key to improve adherence is to identify the unique causes of non-adherence for each patient and to select the correct solutions  One of the most effective measure to improve adherence are based on simplified therapeutic regimen

Questions ?